B-ADRENERGIC RECEPTOR STUCTURE & DESENSITIZATION
B-肾上腺素能受体结构
基本信息
- 批准号:3279141
- 负责人:
- 金额:$ 17.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1983
- 资助国家:美国
- 起止时间:1983-04-01 至 1993-03-31
- 项目状态:已结题
- 来源:
- 关键词:adenylate cyclase beta adrenergic receptor cell free system cyclic AMP diterpenes enzyme induction /repression epinephrine hormone receptor hormone regulation /control mechanism molecular cloning neoplastic cell culture for noncancer research phosphorylation prostaglandin E protein kinase tissue /cell culture
项目摘要
The intent of this proposal is to test our hypothesis that cAmp-
dependent protein kinase (PKA) mediates the rapid physiological
heterologous desensitization of hormonal stimulation of adenylate
cyclase in the S49 wild type (WT) lymphoma cell line. Previous
work had demonstrated only a homologous desensitization in response
to relatively high hormone concentrations, which was independent
of Gs' cAMP, and PKA. We have recently found that cAMP activation
of PKA plays a crucial role in the heterologous desensitization of
the beta-adrenergic receptor (beta-AR) and the prostaglandin E1
(PGE1) receptor in WT cells in response to physiological concentr-
ations of epinephrine or PGE1 (0-20 nM). Use of Mg2+ levels in
our adenylate cyclase assays which mimic intracellular
concentrations (0.1-0.5 mM) revealed: 1) heterologous
desensitization of the WT adenylate cyclase, but not that of cyc
or kin cells, and 2) that addition of dibutyryl cAMP along with
epinephrine to the cyc cells caused heterologous desensitization.
We will pursue a genetic-biochemical approach using the S49 WT and
mutant cells to carry out the following specific aims: 1)
characterization of the heterologous desensitization of the WT
cells and derived clones deficient in either adenylate cyclase or
PKA in response to the treatment of these cells with 0-20 nM PGE1
or epinephrine, with cAMP analogues and forskolin, and with the
hormones in combination with these agents; 2) elucidation of
conditions for cell-free heterologous desensitization of adenylate
cyclase, and use of this system to examine the effects of purified
PKA and phosphatases on the phosphorylation-dephosphorylation of
the beta-AR and the correlation with heterologous desensitization-
resensitization; 3) characterization of the phosphorylation of the
beta-AR in response to treatment of intact cells with low
concentrations of hormones and forskolin; and 4) determination of
the generality of the role of PKA in the heterologous
desensitization of receptors which stimulate adenylate cyclase in
mammalian cell lines.
这项提议的目的是检验我们的假设,即casino-
依赖性蛋白激酶(PKA)介导快速的生理
腺苷酸激素刺激的异源脱敏
在S49野生型(WT)淋巴瘤细胞系中的环化酶。 先前
工作证明,只有一个同源的脱敏反应,
相对较高的激素浓度,这是独立的
Gs的cAMP和PKA。 我们最近发现cAMP激活
PKA在异源脱敏中起着至关重要的作用,
β-肾上腺素能受体(β-AR)和前列腺素E1
(PGE 1)受体在野生型细胞中响应生理浓度-
肾上腺素或PGE 1(0-20 nM)。 使用Mg 2+水平
我们的腺苷酸环化酶试验模拟细胞内
浓度(0.1-0.5 mM)显示:1)异源
WT腺苷酸环化酶的脱敏,而不是cyc
或皮肤细胞,和2)添加二丁酰cAMP沿着
肾上腺素对cyc细胞引起异源性脱敏。
我们将使用S49 WT进行遗传生化方法,
突变细胞进行以下具体目标:1)
WT的异源脱敏的表征
细胞和衍生的克隆缺乏腺苷酸环化酶或
PKA对用0-20 nM PGE 1处理这些细胞的响应
或肾上腺素,与cAMP类似物和毛喉素,并与
激素与这些药物的组合; 2)阐明
腺苷酸的无细胞异源脱敏的条件
环化酶的作用,并使用该系统来检查纯化的环化酶的作用。
蛋白激酶A和磷酸酶对蛋白磷酸化-去磷酸化的影响
β-AR及其与异源脱敏的相关性
再敏化; 3)表征的磷酸化的
β-AR对用低浓度
激素和毛喉素的浓度;和4)测定
PKA在异源细胞中作用的一般性,
刺激腺苷酸环化酶的受体的脱敏
哺乳动物细胞系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD B CLARK其他文献
RICHARD B CLARK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD B CLARK', 18)}}的其他基金
BETA-ADRENERGIC RECEPTOR STRUCTURE AND DESENSITIZATION
β-肾上腺素能受体结构和脱敏
- 批准号:
2900566 - 财政年份:1983
- 资助金额:
$ 17.83万 - 项目类别:
BETA-ADRENERGIC RECEPTOR STRUCTURE AND DESENSITIZATION
β-肾上腺素能受体结构和脱敏
- 批准号:
2684744 - 财政年份:1983
- 资助金额:
$ 17.83万 - 项目类别:
BETA-ADRENERGIC RECEPTOR STRUCTURE AND DESENSITIZATION
β-肾上腺素能受体结构和脱敏
- 批准号:
3279137 - 财政年份:1983
- 资助金额:
$ 17.83万 - 项目类别:
BETA-ADRENERGIC RECEPTOR STRUCTURE AND DESENSITIZATION
β-肾上腺素能受体结构和脱敏
- 批准号:
6606900 - 财政年份:1983
- 资助金额:
$ 17.83万 - 项目类别:
Beta Adrenergic Receptor Structure and Desensitization
β 肾上腺素能受体结构和脱敏
- 批准号:
6871479 - 财政年份:1983
- 资助金额:
$ 17.83万 - 项目类别:
Beta Andrenergic Receptor Structure and Desensitization
β 肾上腺素能受体结构和脱敏
- 批准号:
7937878 - 财政年份:1983
- 资助金额:
$ 17.83万 - 项目类别:
相似海外基金
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
- 批准号:
10629280 - 财政年份:2022
- 资助金额:
$ 17.83万 - 项目类别:
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
- 批准号:
10448574 - 财政年份:2022
- 资助金额:
$ 17.83万 - 项目类别:
Novel regulation of beta-adrenergic receptor function by phosphoinositide 3-kinase
磷酸肌醇 3-激酶对 β-肾上腺素能受体功能的新调节
- 批准号:
10591688 - 财政年份:2022
- 资助金额:
$ 17.83万 - 项目类别:
Cardiac Beta-Adrenergic Receptor Density, Evaluated by Cardiac Positron Emission Tomography, in Heart Failure with Atrial Fibrillation
通过心脏正电子发射断层扫描评估心房颤动心力衰竭患者的心脏β-肾上腺素能受体密度
- 批准号:
22K07801 - 财政年份:2022
- 资助金额:
$ 17.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Research for predictive indicators of therapeutic response of beta-adrenergic receptor blockers using myocardial tissue of patients with heart failure
利用心力衰竭患者心肌组织研究β-肾上腺素能受体阻滞剂治疗反应的预测指标
- 批准号:
21K16031 - 财政年份:2021
- 资助金额:
$ 17.83万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Beta adrenergic receptor-dependent regulation of leukocytes in acute cardiac injury
急性心脏损伤中白细胞的β肾上腺素受体依赖性调节
- 批准号:
10288087 - 财政年份:2017
- 资助金额:
$ 17.83万 - 项目类别:
Beta adrenergic receptor-dependent regulation of leukocytes in acute cardiac injury
急性心脏损伤中白细胞的β肾上腺素受体依赖性调节
- 批准号:
10063903 - 财政年份:2017
- 资助金额:
$ 17.83万 - 项目类别:
Beta adrenergic receptor resensitization in asthma
哮喘中的β肾上腺素能受体再敏化
- 批准号:
9205534 - 财政年份:2016
- 资助金额:
$ 17.83万 - 项目类别:
Impact of cardiac beta-adrenergic receptor density evaluated by cardiac PET on chronotropic incompetence
心脏 PET 评估心脏 β-肾上腺素能受体密度对变时性功能不全的影响
- 批准号:
15K09966 - 财政年份:2015
- 资助金额:
$ 17.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation of the mechanism in the aldosterone regulation through the beta-adrenergic receptor
通过β-肾上腺素受体调节醛固酮的机制研究
- 批准号:
24580463 - 财政年份:2012
- 资助金额:
$ 17.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)